Butensky & Cohen Financial Security, Inc Amgen Inc Transaction History

Butensky & Cohen Financial Security, Inc

$330 Million
Q3 2024

A detailed history of Butensky & Cohen Financial Security, Inc transactions in Amgen Inc stock. As of the latest transaction made, Butensky & Cohen Financial Security, Inc holds 15,936 shares of AMGN stock, worth $4.69 Million. This represents 1.55% of its overall portfolio holdings.

Number of Shares

15,936

Previous 16,176 1.48%

Holding current value

$4.69 Million

Previous $5.05 Million 1.58%

% of portfolio

1.55%

Previous 1.64%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$309.38 - $337.38 $74,251 - $80,971	-240 Reduced 1.48%	15,936 $5.13 Million
Q2 2024 Jul 11, 2024	SELL	$262.75 - $319.31 $3,153 - $3,831	-12 Reduced 0.07%	16,176 $5.05 Million
Q1 2024 Apr 05, 2024	SELL	$268.87 - $324.56 $205,685 - $248,288	-765 Reduced 4.51%	16,188 $4.6 Million
Q4 2023 Jan 16, 2024	SELL	$255.7 - $288.46 $2,301 - $2,596	-9 Reduced 0.05%	16,953 $4.88 Million
Q3 2023 Oct 04, 2023	BUY	$218.65 - $271.46 $130,971 - $162,604	599 Added 3.66%	16,962 $4.56 Million
Q2 2023 Jul 11, 2023	SELL	$214.27 - $253.37 $21,855 - $25,843	-102 Reduced 0.62%	16,363 $3.63 Million
Q1 2023 Apr 11, 2023	BUY	$225.79 - $275.2 $72,027 - $87,788	319 Added 1.98%	16,465 $3.98 Million
Q4 2022 Jan 10, 2023	SELL	$229.03 - $291.01 $196,965 - $250,268	-860 Reduced 5.06%	16,146 $0
Q3 2022 Oct 11, 2022	BUY	$224.46 - $253.15 $228,949 - $258,213	1,020 Added 6.38%	17,006 $3.83 Million
Q2 2022 Jul 14, 2022	SELL	$230.71 - $256.74 $82,824 - $92,169	-359 Reduced 2.2%	15,986 $3.89 Million
Q1 2022 Apr 14, 2022	BUY	$219.27 - $242.57 $132,219 - $146,269	603 Added 3.83%	16,345 $3.95 Million
Q4 2021 Jan 14, 2022	BUY	$198.88 - $227.6 $190,924 - $218,496	960 Added 6.49%	15,742 $3.54 Million
Q3 2021 Oct 13, 2021	BUY	$212.27 - $248.7 $295,479 - $346,190	1,392 Added 10.4%	14,782 $3.14 Million
Q2 2021 Jul 16, 2021	BUY	$233.58 - $259.14 $85,023 - $94,326	364 Added 2.79%	13,390 $3.26 Million
Q1 2021 Apr 13, 2021	BUY	$221.91 - $258.6 $114,727 - $133,696	517 Added 4.13%	13,026 $3.24 Million
Q4 2020 Jan 12, 2021	BUY	$216.38 - $257.67 $303,364 - $361,253	1,402 Added 12.62%	12,509 $2.88 Million
Q3 2020 Oct 13, 2020	SELL	$234.65 - $260.95 $115,447 - $128,387	-492 Reduced 4.24%	11,107 $2.82 Million
Q2 2020 Aug 10, 2020	BUY	$197.81 - $242.74 $33,627 - $41,265	170 Added 1.49%	11,599 $2.74 Million
Q1 2020 Apr 14, 2020	SELL	$182.24 - $241.7 $28,611 - $37,946	-157 Reduced 1.36%	11,429 $2.32 Million
Q4 2019 Jan 15, 2020	SELL	$189.21 - $243.2 $74,548 - $95,820	-394 Reduced 3.29%	11,586 $2.79 Million
Q3 2019 Oct 10, 2019	BUY	$174.11 - $208.62 $189,779 - $227,395	1,090 Added 10.01%	11,980 $2.32 Million
Q2 2019 Jul 12, 2019	BUY	$166.7 - $195.41 $203,874 - $238,986	1,223 Added 12.65%	10,890 $2.01 Million
Q1 2019 Apr 22, 2019	BUY	$180.87 - $203.88 $199,680 - $225,083	1,104 Added 12.89%	9,667 $1.84 Million
Q4 2018 Jan 17, 2019	BUY	$178.4 - $208.25 $55,839 - $65,182	313 Added 3.79%	8,563 $1.67 Million
Q3 2018 Oct 12, 2018	SELL	$185.29 - $208.89 $22,420 - $25,275	-121 Reduced 1.45%	8,250 $1.71 Million
Q2 2018 Jul 18, 2018	BUY	$166.05 - $186.51 $73,560 - $82,623	443 Added 5.59%	8,371 $1.55 Million
Q1 2018 Apr 06, 2018	BUY	$169.43 - $198.0 $83,528 - $97,614	493 Added 6.63%	7,928 $1.35 Million
Q4 2017 Jan 18, 2018	BUY	$168.79 - $188.59 $54,012 - $60,348	320 Added 4.5%	7,435 $1.29 Million
Q3 2017 Oct 20, 2017	BUY	$167.29 - $191.0 $1.19 Million - $1.36 Million	7,115	7,115 $1.33 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Butensky & Cohen Financial Security, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Butensky & Cohen Financial Security, Inc with notifications on news.

Account

Butensky & Cohen Financial Security, Inc Amgen Inc Transaction History